Article / 28 October 2014 at 8:32 GMT

This morning's take on global equities

Head of Equity Strategy / Saxo Bank
By Peter Garnry

Below is a short recap of my comments from our internal morning call.

  1. Record short selling in Japanese equities... with around 35% of daily trading volume being shorted. Normally the most shorted single stocks outperform the general market, so this might be a signal that the market is too pessimistic on Japanese equities and we could see a short-term, short-covering rally.
  2. The market does not believe the European Central Bank... with all banking stocks yesterday erasing early gains following the better-than-expected stress-test results. The truth lies probably in between, with the ECB being a bit too optimistic and investors a bit too pessimistic. Overall, our view is that the stress test will improve valuations among certain banking stocks, such as Commerzbank and Deutsche Bank which are trading at half their book value.
  3. Amgen delivered solid third-quarter earnings after US market close... with EPS at $2.30 vs. an expected $2.11. The company is raising its full-year guidance. We highlighted the stock on yesterday's morning call and we remain very bullish on Amgen.
  4. Twitter Q3 EPS was in line... but the valuation is grotesque given the lack of user growth. We are negative on the stock.
  5. BP issues an implicit profit warning... but the market does not care, sending the stock up around 1% in early London trading as Q3 net income came in a tad better than expected (but Q3 profits were down 19% year-over-year). Gulf of Mexico oil spill costs are now $20 billion but could go as high as $50 billion. Management is issuing a small profit warning due to the sanctions against Russia. BP owns 20% of OAO Rosneft, Russia's largest oil producer.
  6. Lloyds Banking sees a 41% jump in profits... but investors are sending the stock down 1.5% despite announcements of jobs cut and positive trends in impairments. Our quant model is neutral on Lloyds Banking but very bullish on Royal Bank of Scotland, which is reporting its Q3 earnings on Friday. Given today's results from Lloyds, we expect positive results from Royal Bank of Scotland.
  7. Gilead Sciences reports Q3 earnings at 20:00 GMT... with the Street expecting $1.91. Our quant model is extremely bullish on Gilead Sciences and the stock is on our conviction buy list for North America equities.
  8. Facebook reports Q3 earnings after US market close... with analysts expecting earnings to rise 61% y/y on margin expansion and increased monetisation of its international user base. Our quant model is very bullish on Facebook and we will elaborate on our view later today on Saxo TV.
-- Edited by Michael McKenna

Peter Garnry is head of equity strategy at Saxo Bank.
fxtime fxtime
So would you assume to buy the dips in RBS?
Peter Garnry Peter Garnry
Yes, our model would do exactly that...


The Saxo Bank Group entities each provide execution-only service and access to permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on or as a result of the use of the Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. When trading through your contracting Saxo Bank Group entity will be the counterparty to any trading entered into by you. does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of ourtrading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws. Please read our disclaimers:
- Notification on Non-Independent Invetment Research
- Full disclaimer

Check your inbox for a mail from us to fully activate your profile. No mail? Have us re-send your verification mail